Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T.

J Neurosci. 2006 Aug 30;26(35):9022-9.

2.

Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.

Bersudsky Y, Shaldubina A, Kozlovsky N, Woodgett JR, Agam G, Belmaker RH.

Behav Pharmacol. 2008 May;19(3):217-24. doi: 10.1097/FBP.0b013e3282feb099.

PMID:
18469539
3.

Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.

Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leão P, Almeida OF, Sousa N.

Neuroscience. 2008 Mar 27;152(3):656-69. doi: 10.1016/j.neuroscience.2007.12.026. Epub 2007 Dec 23.

PMID:
18291594
4.

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.

O'Brien WT, Harper AD, Jové F, Woodgett JR, Maretto S, Piccolo S, Klein PS.

J Neurosci. 2004 Jul 28;24(30):6791-8.

5.

Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice.

Kondratiuk I, Devijver H, Lechat B, Van Leuven F, Kaczmarek L, Filipkowski RK.

Behav Brain Res. 2013 Jul 1;248:46-50. doi: 10.1016/j.bbr.2013.03.045. Epub 2013 Apr 6.

PMID:
23570858
6.

Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex.

Szymańska M, Suska A, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Leśkiewicz M, Kubera M, Gergont A, Kroczka S, Kaciński M, Lasoń W.

Pharmacol Rep. 2009 Jul-Aug;61(4):612-20.

7.

Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.

Kozikowski AP, Gunosewoyo H, Guo S, Gaisina IN, Walter RL, Ketcherside A, McClung CA, Mesecar AD, Caldarone B.

ChemMedChem. 2011 Sep 5;6(9):1593-602. doi: 10.1002/cmdc.201100188. Epub 2011 Jul 5.

8.

A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.

Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, Tragon T, Hunsberger JG, Machado-Vieira R, Drevets W, Wang YT, Manji HK.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11573-8. doi: 10.1073/pnas.0913138107. Epub 2010 Jun 7.

9.

Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice.

Ahnaou A, Drinkenburg WH.

Behav Brain Res. 2011 Aug 1;221(1):246-52. doi: 10.1016/j.bbr.2011.03.004. Epub 2011 Mar 8.

PMID:
21392539
10.

Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.

Pearce NJ, Arch JR, Clapham JC, Coghlan MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA, Taylor CM, Yates JW, Morrison AD, Harper AJ, Roxbee-Cox L, Abuin A, Wargent E, Holder JC.

Metabolism. 2004 Oct;53(10):1322-30.

PMID:
15375789
11.

Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.

Kirshenboim N, Plotkin B, Shlomo SB, Kaidanovich-Beilin O, Eldar-Finkelman H.

J Mol Neurosci. 2004;24(2):237-45.

PMID:
15456937
12.

Sevoflurane attenuates stress-enhanced fear learning by regulating hippocampal BDNF expression and Akt/GSK-3β signaling pathway in a rat model of post-traumatic stress disorder.

Chen C, Ji M, Xu Q, Zhang Y, Sun Q, Liu J, Zhu S, Li W.

J Anesth. 2015 Aug;29(4):600-8. doi: 10.1007/s00540-014-1964-x. Epub 2014 Dec 23.

PMID:
25533726
13.

Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.

Freitas AE, Machado DG, Budni J, Neis VB, Balen GO, Lopes MW, de Souza LF, Dafre AL, Leal RB, Rodrigues AL.

Behav Brain Res. 2013 Jan 15;237:176-84. doi: 10.1016/j.bbr.2012.09.035. Epub 2012 Sep 24.

PMID:
23018126
14.

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.

Hepatology. 2002 Dec;36(6):1528-36.

PMID:
12447879
15.

Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3).

Ackermann TF, Kempe DS, Lang F, Lang UE.

Cell Physiol Biochem. 2010;25(6):775-86. doi: 10.1159/000315097. Epub 2010 May 18.

16.

Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.

Gould TD, Einat H, O'Donnell KC, Picchini AM, Schloesser RJ, Manji HK.

Neuropsychopharmacology. 2007 Oct;32(10):2173-83. Epub 2007 Feb 14.

18.

Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice.

Zhang K, Song X, Xu Y, Li X, Liu P, Sun N, Zhao X, Liu Z, Xie Z, Peng J.

J Affect Disord. 2013 Mar 20;146(1):45-52. doi: 10.1016/j.jad.2012.08.033. Epub 2012 Sep 28.

PMID:
23021826
20.

Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.

Padiath QS, Paranjpe D, Jain S, Sharma VK.

Chronobiol Int. 2004 Jan;21(1):43-55.

PMID:
15129823

Supplemental Content

Support Center